🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Egypt / NCT07187609
Recruiting Not applicable

Zinc Incorporated Bovine Derived- Hydroxyappatite Xenograft in Immediately Placed Implant

NCT07187609 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-08-13
Last updated
2025-09-23

Condition(s) studied

ImplantZinc Status

Investigational drug(s) / intervention(s)

Immediate implant with bovine drived hydroxyapatite xenograft.immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft

Immediate implant with bovine drived hydroxyapatite xenograft.: patients will undergo immediate implant with bovine drived hydroxyapatite xenograft.

immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft: patients will undergo immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft

Study summary

The aim of this study is to evaluate Clinical and radiographic effect of zinc incorporated bovine derived hydroxyapatite xenograft and bovine hydroxyapatite xenograft alone for immediately placed implant

Eligibility

Sex
ALL
Min age
21 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Adult(male or female) patients between the ages of 21 -50 years who requiring the replacement of one or more non-restorable teeth in the mandible which will be indicated for extraction. * Adequate bone dimensions at the implant site with ridge width of at least 6 mm, the availability of at least 3mm of sound subapical bone, the presence of an intact labial bone plate, and no evidance of periapical infection on cone beam computed tomography or clinically * The peri-implant gaps larger than 1.5 mm will be included. * All patients will be physically healthy with no medical history of any systemic disease. Exclusion Criteria: * Smokers. * Patients with para functional habits such as bruxism and clenching * Poorly controlled systemic diseases which preclude local anesthesia or surgical procedures * Patients undergoing chemotherapy or radiotherapy and immuno-compromised patients. * Pregnant /lactating women. * Patients that are allergic to zinc * Patients on antibiotic therapy in the pervious 6 months

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Suez canal university Suez Egypt Recruiting

More Suez Canal University trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07187609 on ClinicalTrials.gov ↗ ← All trials in Egypt